Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series

Authors :: Nanne K. H. de Boer
Gerard Dijkstra
Annemarie C. de Vries
Vince B. C. Biemans
Andrea Van Der Meulen
Christien J. van der Woude
Jeoffrey J L Haans
Bas Oldenburg
Marie J. Pierik
Frank Hoentjen
Cyriel Y. Ponsioen
Source :: Gastroenterology. 154:S-838
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Series (stratigraphy)
medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
medicine.disease
Inflammatory bowel disease
Vedolizumab
Drug survival
Internal medicine
medicine
business
medicine.drug
Cohort study

Tools